Clinical trial
Effect of Dapagliflozin on Left Ventricular Remodeling in Patients With Acute Myocardial Infarction
NCT04783870 is registered in ClinicalTrials.gov with Instituto Mexicano del Seguro Social as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Dapagliflozin on Left Ventricular Remodeling in Patients With Acute Myocardial Infarction
- Lead sponsor
- Instituto Mexicano del Seguro Social
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- March 3, 2021
- Completion date
- December 31, 2024
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.